Decoy Therapeutics Inc.
DCOY- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001615219
No open-market purchases or sales by Decoy Therapeutics Inc. insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $31.0K in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Decoy Therapeutics Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 11
- +2 vs. Q4 2022
- Shares held
- 97.4K
- +24.1K (+32.9%) vs. Q4 2022
- Total value
- $186.0K
- +$75.1K (+67.7%) vs. Q4 2022
- New holders
- 3
- 2 more added
- Sold out
- 1
- 2 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DCOY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 4 | $31.0K |
| Q1 2026 | 4 | $10.5K |
| Q4 2025 | 9 | $51.4K |
| Q3 2025 | 5 | $1.98K |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 13 | $101.9K |
| Q4 2023 | 16 | $169.8K |
| Q3 2023 | 14 | $226.8K |
| Q2 2023 | 14 | $321.5K |
| Q1 2023 | 11 | $186.0K |
| Q4 2022 | 9 | $110.9K |
| Q3 2022 | 22 | $671.0K |
| Q2 2022 | 27 | $859.0K |
| Q1 2022 | 28 | $1.45M |
| Q4 2021 | 28 | $2.63M |
| Q3 2021 | 27 | $6.84M |
| Q2 2021 | 34 | $10.7M |
| Q1 2021 | 34 | $22.8M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Decoy Therapeutics Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Horizon Kinetics Asset Management LLC | 32,400 | $61.9K | 0.00% | +32,400 | New |
| Renaissance Technologies LLC | 20,042 | $38.0K | 0.00% | +3,700+22.6% | Added |
| Geode Capital Management, LLC | 16,523 | $31.7K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 15,420 | $29.5K | 0.00% | −22,734−59.6% | Reduced |
| Two Sigma Investments, LP | 10,370 | $19.8K | 0.00% | +10,370 | New |
| Advisor Group Holdings, Inc. | 1,387 | $2.65K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,126 | $2.15K | 0.00% | +887+371.1% | Added |
| Morgan Stanley | 60 | $115 | 0.00% | −3−4.8% | Reduced |
| BlackRock Inc. | 47 | $90 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 47 | $90 | 0.00% | +47 | New |
| Wells Fargo & Company | 15 | $29 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −533−100.0% | Sold out |